Dr. Eugene Lipov is a leading expert in the treatment of post-traumatic stress and a pioneer in the use of Stellate Ganglion Block (SGB) to alleviate PTSD symptoms. Inspired by his own family’s struggles with trauma, he has dedicated his career to restoring hope and improving the quality of life for those affected.
In 2006, Dr. Lipov adapted SGB—an FDA-approved procedure since the 1970s, traditionally used for pain and circulation disorders—into a groundbreaking treatment for PTSD. He later developed the Dual Sympathetic Reset (DSR) protocol, enhancing the effectiveness and consistency of patient outcomes.
Beyond his clinical innovations, Dr. Lipov is a passionate advocate for redefining PTSD as post-traumatic stress injury (PTSI), aiming to reduce stigma and shift public perception. In 2010, he testified before the U.S. House Committee on Veterans’ Affairs and has collaborated with military and medical communities worldwide.
Dr. Lipov has published extensively in leading medical journals, and his work has been featured in prominent media outlets including The Wall Street Journal, USA Today, Fox News, and NBC. His mission is to make effective, science-based trauma treatments accessible to people around the world.